t
MedPal AI plc announced on 9 October 2026 that it has posted a shareholder circular convening a General Meeting on its website, which will also be sent to registered shareholders with a form of proxy. The General Meeting is scheduled for 10:00 a.m. on 29 October 2026. Proxy voting opened at 5:00 p.m. on 9 October 2026, with the deadline for receipt of individual proxy forms being 10:00 a.m. on 27 October 2026.
| Date | 9 Oct 2026 |
| Time | 11:00:00 |
| Category | AGMs and other meetings |
| ID | 3737Y |
9 October 2026
MedPal AI plc
(“MedPal”, the “Company” or the “Group”)
Circular and Notice of General Meeting
Further to its announcement of 6 October 2026, MedPal AI plc (AIM: MPAL; FRA: Z1N), the AI-native digital health and pharmacy group, announces that a shareholder circular convening a General Meeting has been posted on the Company’s website at:
www.medpalplc.com/agm-and-gm-notices
The circular, together with a form of proxy, will shortly be sent to registered shareholders. The General Meeting has been convened for 10:00 a.m. on 29 October 2026 at the offices of Wedlake Bell LLP, 71 Queen Victoria Street, London, EC4V 4AY.
Proxy voting will be available from 5:00 p.m. today and instructions can be found in the circular.
EXPECTED TIMETABLE OF PRINCIPAL EVENTS
|
|
Time / Date 2026 |
|
Electronic publication of the circular by |
10:00 a.m. on 9 October
|
|
Posting of Circular to Shareholders |
9 October |
|
Latest time and date for receipt of individual Forms of proxy / electronic proxy appointments |
10:00 a.m. on 27 October
|
|
Record date for attendance at the General Meeting |
6.00 p.m. on 27 October |
|
General Meeting |
10:00 a.m. on 29 October |
Future times and dates are indicative only and are subject to change by the Company. If the expected timetable of events changes from the above, the Company will notify the Shareholders to this effect via Regulatory Information Service.
References to time in this announcement are to London times.
For further information please contact:
Enquiries:
|
MedPal AI plc Jason Drummond, Chief Executive Officer |
Via Square1 Consulting |
|
Cairn Financial Advisers LLP (Nomad) Louise O'Driscoll / Jo Turner |
+44 (0) 20 7213 0880 |
|
Merlin Partners LLP (Broker)
|
+44 (0) 20 7839 3500 |
|
Clear Capital Markets Limited (Broker) Bob Roberts |
+44 (0) 20 3869 6080 |
|
Square1 Consulting – (Financial PR) David Bick |
+44 (0) 20 7929 5599 / +44 (0) 7831 381201 |
|
|
|
About MedPal AI plc
MedPal AI plc (AIM: MPAL; FRA: Z1N) is a vertically integrated, AI-native digital health and pharmacy group. The Group operates NHS Distance Selling Pharmacy hubs at Sarus Court, Runcorn and Swaffham, New Health (new.co.uk), a dedicated GLP-1 weight management clinic, a B2B care home pharmacy supply business, eMARx, the Group’s electronic medication administration record software for care homes, and Juno, an agentic AI health companion built on Anthropic’s Claude. MedPal’s ambition is to build the UK’s leading Health OS: a single platform connecting prescribing, dispensing, delivery, administration and AI-driven patient support. The Company’s LEI is 984500EDP8B0A14CBA61.
END